Antifungal susceptibility and pathogenic potential of environmental isolated filamentous fungi compared with colonizing agents in immunocompromised patients

Mycopathologia

Volumn 160, Issue 2, 2005, Pages 129-135

  Teixeira, A B A ^a   Silva, M ^a   Lyra, L ^a   Luz, E A ^a   Uno, J ^b   Takada, H ^b   Miyaji, M ^b   Nishimura, K ^b   Schreiber, A Z ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

Antifungal agents; Bone marrow transplant; Environmental; Microdilution; Molds

Indexed keywords

ANTIFUNGAL AGENT;

ARTICLE; ASPERGILLUS; BLOOD DISEASE; BONE MARROW TRANSPLANTATION; CLADOSPORIUM; CLASSIFICATION; DEUTEROMYCETES; DRUG EFFECT; FUSARIUM; HUMAN; IMMUNE DEFICIENCY; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MYCOSIS; PATHOGENICITY; TEACHING HOSPITAL;

AIR MICROBIOLOGY; ANTIFUNGAL AGENTS; ASPERGILLUS; BONE MARROW TRANSPLANTATION; CLADOSPORIUM; FUSARIUM; HEMATOLOGIC NEOPLASMS; HOSPITALS, TEACHING; HUMANS; IMMUNOCOMPROMISED HOST; MICROBIAL SENSITIVITY TESTS; MITOSPORIC FUNGI; MYCOSES;

ASPERGILLUS; CLADOSPORIUM; FUNGI; FUSARIUM;

EID: 25444516204     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-005-0117-z     Document Type: Article

References (21)

1. F Monin PH Chandrasekar 1995 Antimicrobial prophylaxis in bone marrow transplantation Ann Intern Med 123 3 205 215
2. JP Debeaupuis J Sarfati V Chazalet JP Latgi 1997 Genetic diversity among clinical and environmental isolates of A. fumigatus Infect Immun 65 3080 3085
3. ACAP Leenders AV Belkum M Behrendt A Luijendijk HA Verbrugh 1999 Density and molecular epidemiology of Aspergillus in air and relationship to outbreaks of Aspergillus infection J Clin Microbiol 37 2343 2345
4. MA Slavin B Osborne R Adams MJ Levenstein HG Schoch AR Feldman JD Meyers RA Bowden 1995 Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation - a prospective, randomized, double-blind study J Infect Dis 171 1545 1552
5. PE Verweij M Mensink AJMM Rijs JP Donnelly JFGM Meis DW Denning 1998 In vitro activities of amphotericin B, itraconazole and voriconazole against 150 clinical and environmental Aspergillus fumigatus isolates The British Society for Antimicrobial Chemotherapy 42 389 392
6. C Lass-Florl GM Salzer T Schmid W Rabl H Ulmer MP Dieriche 1999 Pulmonary Aspergillus colonization in humans and its impact on management of critically ill patients Brit J Haematol 104 745 747
7. SE Vartivarian EJ Anaissie GP Bodey 1993 Emerging fungal pathogens in immunocompromised patients: Classification, diagnosis, and management Clin Infect Dis 17 2 487 91
8. G Castellá J Cano J Guarro FJ Cabañes 1999 DNA fingerprinting of Fusarium solani isolates related to cutaneous infection in a sea turtle Med Mycol 37 223 226
9. Y Sugiura JR Barr DB Barr JW Brock CM Elie Y Ueno DGJ Patterson ME Potter E Reiss 1999 Physiological characteristics and mycotoxins of human clinical isolates of Fusarium species Mycol Res 103 11 1462 1468
10. I Raad R Hachen 1995 Treatment of central venous catheter-related fugemia due to Fusarium oxysporum Clin Infect Dis 20 709 711
11. SW Crawford 1993 Bone marrow transplantation and related infections Semin Respir Infect 8 3 183 190
12. DJ Drutz 1987 In vitro antifungal susceptibility testing and measurement of levels of antifungal agents in body fluids Rev Infect Dis 9 2 392 397
13. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi. Approved standard M38-A. National Committee for Clinical Laboratory Standards 2002; Wayne, PA.
14. K Krasinski RS Holzman B Hanna MA Greco M Graff M Bhogal 1985 Nosocomial fungal infection during hospital renovation Infect Cont 6 1 278 282
15. PC Iwen JC Davis EC Reed BA Winfield SH Heinrichs 1994 Airborne fungal spore monitoring in a protective environment during hospital construction, and correlation with an outbreak of invasive Aspergillosis Infect Cont Hosp Ep 15 5 303 306
16. MB Ellis 1971 Dematiaceous Hyphomycetes 1 England Commonwealth Mycological Institute Surrey
17. Raper BK. 1965. The Genus Aspergillus, (1) Williams & Wilkins Company, Baltimore USA.
18. Chazatet V, Debeaupuis JP, Sarfati J, Lortholary J, Ribaud P, Shah P, Cornet M, Thien HV, Gluckman E, Brucker G, Latgé JP. Molecular typing of environmental and patient isolates of Aspergillus fumigatus from various hospital settings. J Clin Microbiol. 1998; 1494-1500.
19. TG Jensen B Gahrn-Hansen M Arendrup B Bruun 2004 Fusarium fungaemia in immunocompromised patients Clin Microbiol Infect 10 6 499 501
20. ABA Teixeira P Trabasso ML Moretti FH Aoki AC Vigorito M Miyaji Y Mikami M Takada AZ. Schreiber 2003 Phaeohyphomycosis caused by Chaetomium globosum in an allogeneic bone marrow transplant recipient Mycopathologia 56 309 312
21. I Pujol J Guarro J Gené J Sala 1997 In vitro antifungal susceptibility of clinical and environmental Fusarium spp. strains J Antimicrob Chemotherapy 39 163 167